19 years of historical data (2007–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Addus HomeCare Corporation trades at 18.1x earnings, 37% below its 5-year average of 28.6x, sitting at the 20th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 18%. On a free-cash-flow basis, the stock trades at 16.9x P/FCF, 25% below the 5-year average of 22.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.8B | $2.0B | $2.2B | $1.5B | $1.6B | $1.5B | $1.9B | $1.4B | $891M | $405M | $404M |
| Enterprise Value | $1.9B | $2.1B | $2.4B | $1.6B | $1.7B | $1.6B | $2.0B | $1.4B | $838M | $394M | $421M |
| P/E Ratio → | 18.09 | 20.61 | 29.63 | 24.24 | 35.03 | 33.28 | 56.29 | 54.93 | 51.04 | 29.74 | 33.70 |
| P/S Ratio | 1.24 | 1.39 | 1.89 | 1.43 | 1.69 | 1.74 | 2.44 | 2.14 | 1.72 | 0.95 | 1.01 |
| P/B Ratio | 1.60 | 1.83 | 2.24 | 2.14 | 2.54 | 2.62 | 3.60 | 2.91 | 3.23 | 2.31 | 2.54 |
| P/FCF | 16.93 | 19.09 | 19.74 | 14.73 | 16.63 | 43.11 | 18.21 | 187.24 | 31.99 | 8.24 | — |
| P/OCF | 15.75 | 17.77 | 18.71 | 13.49 | 15.32 | 38.04 | 17.08 | 115.25 | 26.83 | 7.67 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Addus HomeCare Corporation's enterprise value stands at 12.2x EBITDA, 32% below its 5-year average of 18.0x. The Healthcare sector median is 14.2x, placing the stock at a 15% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.48 | 2.04 | 1.53 | 1.80 | 1.85 | 2.57 | 2.09 | 1.62 | 0.93 | 1.05 |
| EV / EBITDA | 12.15 | 13.60 | 20.24 | 15.46 | 20.63 | 19.85 | 34.71 | 29.89 | 26.63 | 12.34 | 19.03 |
| EV / EBIT | 13.59 | 15.38 | 21.97 | 17.58 | 24.72 | 24.12 | 43.49 | 37.35 | 32.96 | 14.78 | 23.07 |
| EV / FCF | — | 20.31 | 21.31 | 15.81 | 17.64 | 45.83 | 19.14 | 183.14 | 30.08 | 8.02 | — |
Margins and return-on-capital ratios measuring operating efficiency
Addus HomeCare Corporation earns an operating margin of 9.7%. Operating margins have expanded from 8.6% to 9.7% over the past 3 years, signaling improving operational efficiency. ROE of 9.3% is modest. ROIC of 8.8% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.5% | 32.5% | 32.5% | 32.1% | 31.5% | 31.2% | 29.6% | 27.6% | 26.7% | 27.2% | 26.5% |
| Operating Margin | 9.7% | 9.7% | 8.9% | 8.6% | 7.2% | 7.6% | 5.8% | 5.4% | 4.4% | 5.9% | 3.9% |
| Net Profit Margin | 6.7% | 6.7% | 6.4% | 5.9% | 4.8% | 5.2% | 4.3% | 3.9% | 3.4% | 3.2% | 3.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.3% | 9.3% | 8.8% | 9.3% | 7.6% | 8.3% | 6.7% | 6.7% | 7.8% | 8.1% | 8.0% |
| ROA | 6.7% | 6.7% | 6.0% | 6.4% | 4.9% | 4.9% | 4.3% | 5.1% | 5.6% | 5.5% | 5.7% |
| ROIC | 8.8% | 8.8% | 7.9% | 8.8% | 7.4% | 7.7% | 6.3% | 7.8% | 8.9% | 11.1% | 7.3% |
| ROCE | 10.9% | 10.9% | 9.6% | 10.8% | 8.4% | 8.4% | 6.9% | 8.2% | 9.0% | 12.7% | 9.3% |
Solvency and debt-coverage ratios — lower is generally safer
Addus HomeCare Corporation carries a Debt/EBITDA ratio of 1.3x, which is manageable (58% below the sector average of 3.2x). Net debt stands at $127M ($209M total debt minus $82M cash). Interest coverage of 14.3x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.19 | 0.19 | 0.28 | 0.25 | 0.28 | 0.46 | 0.46 | 0.17 | 0.06 | 0.25 | 0.16 |
| Debt / EBITDA | 1.35 | 1.35 | 2.35 | 1.67 | 2.15 | 3.28 | 4.24 | 1.80 | 0.55 | 1.35 | 1.13 |
| Net Debt / Equity | — | 0.12 | 0.18 | 0.16 | 0.15 | 0.16 | 0.18 | -0.06 | -0.19 | -0.06 | 0.11 |
| Net Debt / EBITDA | 0.82 | 0.82 | 1.50 | 1.05 | 1.18 | 1.18 | 1.67 | -0.67 | -1.69 | -0.34 | 0.77 |
| Debt / FCF | — | 1.22 | 1.58 | 1.07 | 1.01 | 2.72 | 0.92 | -4.09 | -1.91 | -0.22 | — |
| Interest Coverage | 14.30 | 14.30 | 13.85 | 8.32 | 7.76 | 11.40 | 14.15 | 11.68 | 5.07 | 5.96 | 7.83 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.80x means Addus HomeCare Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.38x to 1.80x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Quick Ratio | 1.80 | 1.80 | 1.67 | 1.38 | 1.70 | 2.76 | 2.00 | 3.08 | 2.86 | 2.98 | 2.64 |
| Cash Ratio | 0.55 | 0.55 | 0.63 | 0.45 | 0.61 | 1.44 | 1.01 | 1.28 | 1.14 | 1.03 | 0.16 |
| Asset Turnover | — | 0.99 | 0.82 | 1.03 | 1.01 | 0.91 | 0.86 | 1.02 | 1.46 | 1.59 | 1.73 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 38.92 | 42.76 | 40.02 | 48.42 | 61.67 | 64.20 | 86.21 | 70.85 | 80.19 | 107.26 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Addus HomeCare Corporation does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 5.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.5% | 4.9% | 3.4% | 4.1% | 2.9% | 3.0% | 1.8% | 1.8% | 2.0% | 3.4% | 3.0% |
| FCF Yield | 5.9% | 5.2% | 5.1% | 6.8% | 6.0% | 2.3% | 5.5% | 0.5% | 3.1% | 12.1% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $18M | $17M | $16M | $16M | $16M | $16M | $14M | $13M | $12M | $12M |
Compare ADUS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $2B | 18.1 | 12.2 | 16.9 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 | |
| $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 | |
| $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 | |
| $2B | -23.9 | 10.1 | 9.7 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 | |
| $4B | -5908.1 | 93.4 | 39.5 | 12.4% | 0.4% | -0.5% | — | 7.5 | |
| $1B | 39.8 | 26.7 | 44.2 | 12.9% | 5.4% | 8.6% | 5.6% | 7.6 | |
| $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 | |
| $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 | |
| $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| $43B | 36.7 | 22.9 | 115.5 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 | |
| $30B | -4.5 | — | 7.0 | 12.2% | -3.9% | -28.7% | -21.6% | — | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 19 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ADUS stock.
Addus HomeCare Corporation's current P/E ratio is 18.1x. The historical average is 29.5x. This places it at the 20th percentile of its historical range.
Addus HomeCare Corporation's current EV/EBITDA is 12.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.6x.
Addus HomeCare Corporation's return on equity (ROE) is 9.3%. The historical average is 7.9%.
Based on historical data, Addus HomeCare Corporation is trading at a P/E of 18.1x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Addus HomeCare Corporation has 32.5% gross margin and 9.7% operating margin.
Addus HomeCare Corporation's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.